Supported byOwner's Engineer
Clarion Energy banner

The pharmaceutical company Galenika achieved a strategic expansion of its product portfolio

Supported byspot_img

During the previous year, in Serbia and the regional markets where it operates, Galenika registered 129 products, while 77 were put into circulation. The company has increased the number of certificates for the highest level of work and production standards, and is now the holder of 18 domestic and international GMP, ISO and HACCP certificates. In addition to Serbia, Galenika successfully operates in 20 international markets, while in 2024 it is planned to expand operations to 4 more markets in Europe and the MENA region.

As part of the Brazilian NC Group and with a strategic partnership with the Brazilian pharmaceutical leader – EMS, during 2023 Galenika successfully realized the transfer of technology for 6 products from the newer generation of generic drugs, and in 2024 the preparation for the realization of the transfer of technology for another 6 products began.

“Regardless of the challenges due to global circumstances, in 2023 Galenika successfully ensured the production and distribution of its products in all markets where it operates. Quality is the basic prerequisite of Galenika’s business philosophy and one of the pillars of our sustainable business culture and social responsibility. In 2024, Galenika remains strategically focused on growth through high quality products, investments, digital transformation and further globalization of its business,” said Ricardo Vian Marques, CEO of Galenika.

Supported by

Responsible business is a high priority. Compared to 2022, in 2023 Galenika reduced the amount of generated waste by 20% and water consumption by 4%. In order to ensure maximum savings and minimum loss of water, in March 2024, it is planned to complete the renovation of the internal water supply system, an investment in which seven hundred thousand euros were invested. During the previous year, the company realized donations of medical equipment for 3 health institutions as well as 47 donations of medicines for 35 health institutions in Serbia.

Galenika continuously takes care and invests in the education of its employees and partners. In the field of education, in accordance with the needs of modern business, the company has doubled the total number of hours invested in employee training. The company’s commitment to developing female leadership potential and recognizing the value of diversity is also indicated by the fact that 64% of managers in Galenica are women, which is even 17% more than in 2022. During 2023, as part of its own program, Galenika Academy, the company realized training for almost eleven thousand pharmacists and pharmaceutical technicians, i.e. 70% of the pharmacy community in Serbia. Additionally, Galenika organized as many as 87 professional medical events for 1,100 healthcare workers from Serbia.

Support to the community in the field of long-term prevention awareness projects was not missing during 2023, while the company continues to expand initiatives of this type in the countries of the region.

Supported by


Supported byClarion Energy
Serbia Energy News
error: Content is protected !!